Abstract
Hematopoietic stem cell transplantation (HSCT) is a widely accepted therapy with potentially curative benefit for patients with benign and malignant hematologic disorders. There are currently three possible sources of allogeneic hematopoietic stem cells (HSCs) - bone marrow, granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood (PBSC), and umbilical cord blood (CB). Donors can be either related or unrelated and must match recipients at human leukocyte antigens (HLA). Based on the average size of American families, and the 25% probability that a given sibling pair will be HLA-matched, it is estimated that approximately 35% of persons in the United States will have an HLA-matched sibling.
Original language | English (US) |
---|---|
Title of host publication | Leukemia and Related Disorders |
Subtitle of host publication | Integrated Treatment Approaches |
Publisher | Springer New York |
Pages | 219-249 |
Number of pages | 31 |
ISBN (Electronic) | 9781607615651 |
ISBN (Print) | 9781607615644 |
DOIs | |
State | Published - Jan 1 2012 |
Externally published | Yes |
Keywords
- Alternative donor
- Bone marrow
- Granulocyte colony-stimulating factor
- Hematopoietic stem cell transplantation
- Leukemia
- Mobilized peripheral blood
- Stem cells
- Transplantation
- Umbilical cord blood
ASJC Scopus subject areas
- Medicine(all)